Can a genetic test predict who will benefit from chemo?

This study aims to develop a model that uses genetic information from tumor tissue to predict how well gastric cancer patients will respond to chemotherapy. Researchers will analyze RNA splicing patterns and apply machine learning to identify patients who are less likely to benefit from standard treatment. The study involves 329 participants with stage II or III gastric cancer who have already had surgery and received chemotherapy. The goal is to help doctors make more informed treatment decisions.